We recognized two glycosyltransferases that contribute to the structural diversification of flavonol glycosides in grapevine (Vitis vinifera): glycosyltransferase 5 (Vv GT5) and Vv GT6. Biochemical analyses confirmed that Vv GT5 is a UDP-glucuronic acid:flavonol-3-O-glucuronosyltransferase (GAT), and Vv GT6 is a bifunctional UDP-glucose/UDP-galactose:flavonol-3-O-glucosyltransferase/galactosyltransferase.
The Vv GT5 and Vv GT6 genes have very excessive sequence similarity (91%) and are positioned in tandem on chromosome 11, suggesting that one of these genes arose from the different by gene duplication. Both of these enzymes had been expressed in accordance with flavonol synthase gene expression and flavonoid distribution patterns in this plant, corroborating their significance in flavonol glycoside biosynthesis.
The determinant of the specificity of Vv GT5 for UDP-glucuronic acid was discovered to be Arg-140, which corresponded to none of the determinants beforehand recognized for different plant GATs in major buildings, offering one other instance of convergent evolution of plant GAT. We additionally analyzed the determinants of the sugar donor specificity of Vv GT6.
Gln-373 and Pro-19 had been discovered to play necessary roles in the bifunctional specificity of the enzyme. The outcomes introduced right here recommend that the sugar donor specificities of these Vv GTs might be decided by a restricted quantity of amino acid substitutions in the major buildings of protein duplicates, illustrating the plasticity of plant glycosyltransferases in buying new sugar donor specificities.
Regression analyses indicated no direct relationship between photosynthesis and leaf ranges of UV-B-absorbing compounds. UV-B radiation elevated photosynthetic pigment content material, together with UV-B-absorbing compounds, however solely the former (particularly carotenoids) was associated to complete biomass (r2 = 0.61, linear) and to photosynthetic effectivity (unfavorable, exponential relationship, r2 = 0.82). A discount in photosynthesis was related primarily with a stomatal limitation somewhat than photosystem II harm.
This research suggests that each carotenoids and flavonoids could also be concerned in plant UV-B photoprotection, however solely carotenoids are instantly linked to photoprotection of photosynthetic operate. These outcomes moreover present the significance of UV-A management in UV-B experiments carried out utilizing synthetic lamps and filters.
Central nervous system depressant motion of flavonoid glycosides.
The pharmacological results on the central nervous system (CNS) of a variety of obtainable flavonoid glycosides had been explored and in contrast to these of the glycosides 2S-hesperidin and linarin, just lately remoted from valeriana. The glycosides 2S-neohesperidin, 2S-naringin, diosmin, gossipyn and rutin exerted a depressant motion on the CNS of mice following i.p. injection, related to that discovered with 2S-hesperidin and linarin.
We display in this work that these behavioural actions, as measured in the gap board, thiopental induced sleeping time and locomotor exercise checks, are unlikely to contain a direct motion on gamma-aminobutyric acid sort A (GABA(A)) receptors. The corresponding aglycones had been inactive, pointing to the significance of the sugar moieties in the glycosides in their CNS depressant motion following systemic administration.
The pharmacological properties of the flavonoid glycosides studied right here, in addition to our earlier outcomes with hesperidin and linarin, opens a promising new avenue of analysis in the subject. Aeruginosins symbolize a bunch of peptide metabolites remoted from varied cyanobacterial genera and from marine sponges that potently inhibit differing types of serine proteases.

Members of this household are characterised by the presence of a 2-carboxy-6-hydroxyoctahydroindole (Choi) moiety. We have recognized and absolutely sequenced a NRPS gene cluster in the genome of the cyanobacterium Planktothrix agardhii CYA126/8. Insertional mutagenesis of a NRPS element led to the discovery and structural elucidation of two glycopeptides that had been designated aeruginoside 126A and aeruginoside 126B.
One variant of the aglycone incorporates a 1-amino-2-(N-amidino-Delta(3)-pyrrolinyl)ethyl moiety at the C terminus, the different bears an agmatine residue. In silico analyses of the aeruginoside biosynthetic genes aerA-aerI in addition to extra mutagenesis and feeding research allowed the prediction of enzymatic steps main to the formation of aeruginosides and the uncommon Choi moiety.
Bioavailability of the flavanone naringenin and its glycosides in rats.
Naringenin, the predominant flavanone in grapefruit, primarily happens as glycosides akin to naringenin-7- rhamnoglucoside or naringenin-7-glucoside. This research in contrast kinetics of absorption of naringenin and its glycosides in rats both after a single flavanone-containing meal or after adaptation to a weight loss program for 14 days.
Regardless of the weight loss program, circulating metabolites had been glucurono- and sulfoconjugated derivatives of naringenin. The kinetics of absorption of naringenin and naringenin-7-glucoside had been related, whereas naringenin-7-rhamnoglucoside exhibited a delay in its intestinal absorption, ensuing in decreased bioavailability.
After naringenin-7-glucoside feeding, no glucoside was discovered in the cecum. However, after feeding naringenin-7-rhamnoglucoside, some naringenin-7-rhamnoglucoside gathered in cecum earlier than being hydrolyzed by intestinal microflora. Adaptation to flavanone diets didn’t induce accumulation of plasma naringenin.
Moreover, flavanone cecal content material markedly decreased after adaptation, and nearly no naringenin-7-rhamnoglucoside was recovered after naringenin-7-rhamnoglucoside feeding, suggesting that an adaptation of cecal microflora had occurred. Overall, these information point out that flavanones are effectively absorbed after feeding to rats and that their bioavailability is said to their glycosidic moiety.
This outcomes in half from the design of UV-B experiments in which experimental UV-A irradiance has not been rigorously managed, since blue/UV-A radiation is concerned in the biosynthesis of the photosynthetic pigments. The relationship of flavonoids to photosynthetic efficiency, photosynthetic pigments, and progress measures was examined in an experiment the place UV-A management teams had been included at two biologically efficient every day UV-B irradiances, 14.1 and 10.7 kJ m-2.
Mouse Protectin (CD59) ELISA Kit |
RD-CD59-Mu-96Tests |
Reddot Biotech |
96 Tests |
EUR 850.8 |
Human Protectin (CD59) ELISA Kit |
RDR-CD59-Hu-48Tests |
Reddot Biotech |
48 Tests |
EUR 626.4 |
Human Protectin (CD59) ELISA Kit |
RDR-CD59-Hu-96Tests |
Reddot Biotech |
96 Tests |
EUR 868.8 |
Mouse Protectin (CD59) ELISA Kit |
RDR-CD59-Mu-48Tests |
Reddot Biotech |
48 Tests |
EUR 640.8 |
Mouse Protectin (CD59) ELISA Kit |
RDR-CD59-Mu-96Tests |
Reddot Biotech |
96 Tests |
EUR 890.4 |
Mouse Monoclonal Anti-Human CD59, (Biotin) (Clone 1F5) (mouse IgG1) |
CD59-B |
Alpha Diagnostics |
25 tests |
EUR 489.6 |
Mouse Monoclonal Anti-Human CD59, (FITC) (Clone 1F5) (mouse IgG1) |
CD59-F |
Alpha Diagnostics |
25 tests |
EUR 489.6 |
Mouse Monoclonal Anti-Human CD59, (PE) (Clone 1F5) (mouse IgG1) |
CD59-PE |
Alpha Diagnostics |
25 tests |
EUR 489.6 |
Mouse CD59 Glycoprotein (CD59) ELISA Kit |
20-abx154584 |
Abbexa |
-
EUR 8684.40
-
EUR 4626.00
-
EUR 1074.00
|
- 10 × 96 tests
- 5 × 96 tests
- 96 tests
|
|
Human CD59 Glycoprotein (CD59) ELISA Kit |
20-abx152853 |
Abbexa |
-
EUR 8534.40
-
EUR 4550.40
-
EUR 1054.80
|
- 10 × 96 tests
- 5 × 96 tests
- 96 tests
|
|
Chicken CD59 Glycoprotein (CD59) ELISA Kit |
abx356537-96tests |
Abbexa |
96 tests |
EUR 990 |
|
Monkey CD59 Glycoprotein (CD59) ELISA Kit |
abx360041-96tests |
Abbexa |
96 tests |
EUR 990 |
|
Pig CD59 Glycoprotein (CD59) ELISA Kit |
abx361750-96tests |
Abbexa |
96 tests |
EUR 990 |
|
Rabbit CD59 Glycoprotein (CD59) ELISA Kit |
abx362655-96tests |
Abbexa |
96 tests |
EUR 990 |
|
Human CD59 Glycoprotein (CD59) ELISA Kit |
abx251445-96tests |
Abbexa |
96 tests |
EUR 848.4 |
|
Pig CD59 Glycoprotein (CD59) ELISA Kit |
abx519457-96tests |
Abbexa |
96 tests |
EUR 990 |
|
Human CD59 Glycoprotein (CD59) ELISA Kit |
abx575604-96tests |
Abbexa |
96 tests |
EUR 848.4 |
|
Rat CD59 Glycoprotein (CD59) ELISA Kit |
abx256610-96tests |
Abbexa |
96 tests |
EUR 801.6 |
|
Human CD59 glycoprotein(CD59) ELISA kit |
CSB-EL004947HU-24T |
Cusabio |
1 plate of 24 wells |
EUR 198 |
|
Description: Quantitativesandwich ELISA kit for measuring Human CD59 glycoprotein (CD59) in samples from serum, plasma, tissue homogenates, urine. A new trial version of the kit, which allows you to test the kit in your application at a reasonable price. |
Human CD59 glycoprotein(CD59) ELISA kit |
1-CSB-EL004947HU |
Cusabio |
-
EUR 964.80
-
EUR 6118.80
-
EUR 3244.80
|
- 1 plate of 96 wells
- 10 plates of 96 wells each
- 5 plates of 96 wells each
|
|
Description: Quantitativesandwich ELISA kit for measuring Human CD59 glycoprotein(CD59) in samples from serum, plasma, tissue homogenates, urine. Now available in a cost efficient pack of 5 plates of 96 wells each, conveniently packed along with the other reagents in 5 separate kits. |
Goat CD59 glycoprotein(CD59) ELISA kit |
E06C1490-192T |
BlueGene |
192 tests |
EUR 1524 |
|
Description: A sandwich ELISA for quantitative measurement of Goat CD59 glycoprotein(CD59) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Goat CD59 glycoprotein(CD59) ELISA kit |
E06C1490-48 |
BlueGene |
1 plate of 48 wells |
EUR 624 |
|
Description: A sandwich ELISA for quantitative measurement of Goat CD59 glycoprotein(CD59) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Goat CD59 glycoprotein(CD59) ELISA kit |
E06C1490-96 |
BlueGene |
1 plate of 96 wells |
EUR 822 |
|
Description: A sandwich ELISA for quantitative measurement of Goat CD59 glycoprotein(CD59) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Human CD59/ CD59 glycoprotein ELISA Kit |
E0432Hu |
Sunlong |
1 Kit |
EUR 685.2 |
Rabbit CD59 glycoprotein(CD59) ELISA kit |
E04C1490-192T |
BlueGene |
192 tests |
EUR 1524 |
|
Description: A sandwich ELISA for quantitative measurement of Rabbit CD59 glycoprotein(CD59) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Rabbit CD59 glycoprotein(CD59) ELISA kit |
E04C1490-48 |
BlueGene |
1 plate of 48 wells |
EUR 624 |
|
Description: A sandwich ELISA for quantitative measurement of Rabbit CD59 glycoprotein(CD59) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Rabbit CD59 glycoprotein(CD59) ELISA kit |
E04C1490-96 |
BlueGene |
1 plate of 96 wells |
EUR 822 |
|
Description: A sandwich ELISA for quantitative measurement of Rabbit CD59 glycoprotein(CD59) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Rat Cd59/ CD59 glycoprotein ELISA Kit |
E0182Ra |
Sunlong |
1 Kit |
EUR 685.2 |
Rat Cd59(CD59 glycoprotein) ELISA Kit |
ER0635 |
FN Test |
96T |
EUR 681.12 |
|
Description: Method of detection: Double Antibody, Sandwich ELISA;Reacts with: Rattus;Sensitivity: 0.094 ng/ml |
Human CD59(CD59 glycoprotein) ELISA Kit |
EH2112 |
FN Test |
96T |
EUR 628.92 |
|
Description: Method of detection: Double Antibody, Sandwich ELISA;Reacts with: Homo sapiens;Sensitivity: 18.75pg/ml |
Pig CD59 glycoprotein(CD59) ELISA kit |
E07C1490-192T |
BlueGene |
192 tests |
EUR 1524 |
|
Description: A sandwich ELISA for quantitative measurement of Porcine CD59 glycoprotein(CD59) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Pig CD59 glycoprotein(CD59) ELISA kit |
E07C1490-48 |
BlueGene |
1 plate of 48 wells |
EUR 624 |
|
Description: A sandwich ELISA for quantitative measurement of Porcine CD59 glycoprotein(CD59) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Pig CD59 glycoprotein(CD59) ELISA kit |
E07C1490-96 |
BlueGene |
1 plate of 96 wells |
EUR 822 |
|
Description: A sandwich ELISA for quantitative measurement of Porcine CD59 glycoprotein(CD59) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Monkey CD59 glycoprotein(CD59) ELISA kit |
E09C1490-192T |
BlueGene |
192 tests |
EUR 1524 |
|
Description: A sandwich ELISA for quantitative measurement of Monkey CD59 glycoprotein(CD59) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Monkey CD59 glycoprotein(CD59) ELISA kit |
E09C1490-48 |
BlueGene |
1 plate of 48 wells |
EUR 624 |
|
Description: A sandwich ELISA for quantitative measurement of Monkey CD59 glycoprotein(CD59) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Monkey CD59 glycoprotein(CD59) ELISA kit |
E09C1490-96 |
BlueGene |
1 plate of 96 wells |
EUR 822 |
|
Description: A sandwich ELISA for quantitative measurement of Monkey CD59 glycoprotein(CD59) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Dog CD59 glycoprotein(CD59) ELISA kit |
E08C1490-192T |
BlueGene |
192 tests |
EUR 1524 |
|
Description: A sandwich ELISA for quantitative measurement of Canine CD59 glycoprotein(CD59) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Dog CD59 glycoprotein(CD59) ELISA kit |
E08C1490-48 |
BlueGene |
1 plate of 48 wells |
EUR 624 |
|
Description: A sandwich ELISA for quantitative measurement of Canine CD59 glycoprotein(CD59) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Dog CD59 glycoprotein(CD59) ELISA kit |
E08C1490-96 |
BlueGene |
1 plate of 96 wells |
EUR 822 |
|
Description: A sandwich ELISA for quantitative measurement of Canine CD59 glycoprotein(CD59) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Rat CD59 glycoprotein(CD59) ELISA kit |
E02C1490-192T |
BlueGene |
192 tests |
EUR 1524 |
|
Description: A sandwich ELISA for quantitative measurement of Rat CD59 glycoprotein(CD59) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Rat CD59 glycoprotein(CD59) ELISA kit |
E02C1490-48 |
BlueGene |
1 plate of 48 wells |
EUR 624 |
|
Description: A sandwich ELISA for quantitative measurement of Rat CD59 glycoprotein(CD59) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Rat CD59 glycoprotein(CD59) ELISA kit |
E02C1490-96 |
BlueGene |
1 plate of 96 wells |
EUR 822 |
|
Description: A sandwich ELISA for quantitative measurement of Rat CD59 glycoprotein(CD59) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Human CD59 glycoprotein(CD59) ELISA kit |
E01C1490-192T |
BlueGene |
192 tests |
EUR 1524 |
|
Description: A sandwich ELISA for quantitative measurement of Human CD59 glycoprotein(CD59) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Human CD59 glycoprotein(CD59) ELISA kit |
E01C1490-48 |
BlueGene |
1 plate of 48 wells |
EUR 624 |
|
Description: A sandwich ELISA for quantitative measurement of Human CD59 glycoprotein(CD59) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Human CD59 glycoprotein(CD59) ELISA kit |
E01C1490-96 |
BlueGene |
1 plate of 96 wells |
EUR 822 |
|
Description: A sandwich ELISA for quantitative measurement of Human CD59 glycoprotein(CD59) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Mouse CD59 glycoprotein(CD59) ELISA kit |
E03C1490-192T |
BlueGene |
192 tests |
EUR 1524 |
|
Description: A sandwich ELISA for quantitative measurement of Mouse CD59 glycoprotein(CD59) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Mouse CD59 glycoprotein(CD59) ELISA kit |
E03C1490-48 |
BlueGene |
1 plate of 48 wells |
EUR 624 |
|
Description: A sandwich ELISA for quantitative measurement of Mouse CD59 glycoprotein(CD59) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Mouse CD59 glycoprotein(CD59) ELISA kit |
E03C1490-96 |
BlueGene |
1 plate of 96 wells |
EUR 822 |
|
Description: A sandwich ELISA for quantitative measurement of Mouse CD59 glycoprotein(CD59) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Rabbit CD59 glycoprotein, CD59 ELISA KIT |
ELI-06798Ra |
Lifescience Market |
96 Tests |
EUR 1113.6 |
Porcine CD59 glycoprotein, CD59 ELISA KIT |
ELI-06799p |
Lifescience Market |
96 Tests |
EUR 1113.6 |
Human CD59 glycoprotein (CD59) |
1-CSB-EP004947HU |
Cusabio |
-
EUR 456.00
-
EUR 256.80
-
EUR 1570.80
-
EUR 672.00
-
EUR 1047.60
-
EUR 314.40
|
- 100ug
- 10ug
- 1MG
- 200ug
- 500ug
- 50ug
|
|
Description: Recombinant Human CD59 glycoprotein(CD59) expressed in E.coli |
Human CD59 glycoprotein (CD59) |
1-CSB-YP004947HU |
Cusabio |
-
EUR 516.00
-
EUR 280.80
-
EUR 1809.60
-
EUR 770.40
-
EUR 1210.80
-
EUR 349.20
|
- 100ug
- 10ug
- 1MG
- 200ug
- 500ug
- 50ug
|
|
Description: Recombinant Human CD59 glycoprotein(CD59) expressed in Yeast |
Guinea pig CD59 Glycoprotein (CD59) ELISA Kit |
abx357782-96tests |
Abbexa |
96 tests |
EUR 990 |
|
Guinea pig CD59 glycoprotein(CD59) ELISA kit |
E05C1490-192T |
BlueGene |
192 tests |
EUR 1524 |
|
Description: A sandwich ELISA for quantitative measurement of Guinea pig CD59 glycoprotein(CD59) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Guinea pig CD59 glycoprotein(CD59) ELISA kit |
E05C1490-48 |
BlueGene |
1 plate of 48 wells |
EUR 624 |
|
Description: A sandwich ELISA for quantitative measurement of Guinea pig CD59 glycoprotein(CD59) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Guinea pig CD59 glycoprotein(CD59) ELISA kit |
E05C1490-96 |
BlueGene |
1 plate of 96 wells |
EUR 822 |
|
Description: A sandwich ELISA for quantitative measurement of Guinea pig CD59 glycoprotein(CD59) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Cd59 ELISA Kit| Rat CD59 glycoprotein ELISA Kit |
EF017452 |
Lifescience Market |
96 Tests |
EUR 826.8 |
ELISA kit for Human CD59 glycoprotein |
EK4299 |
SAB |
96 tests |
EUR 663.6 |
Description: Enzyme-linked immunosorbent assay kit for quantification of Human CD59 glycoprotein in samples from serum, plasma, tissue homogenates and other biological fluids. |
ELISA kit for Rat CD59 glycoprotein |
EK4301 |
SAB |
96 tests |
EUR 663.6 |
Description: Enzyme-linked immunosorbent assay kit for quantification of Rat CD59 glycoprotein in samples from serum, plasma, tissue homogenates and other biological fluids. |
CD59 glycoprotein Polyclonal Antibody |
42110-100ul |
SAB |
100ul |
EUR 399.6 |
Porcine CD59 ELISA Kit |
EPP0359 |
Abclonal |
96Tests |
EUR 625.2 |
Rabbit CD59 ELISA Kit |
ERTP0359 |
Abclonal |
96Tests |
EUR 625.2 |
Rat CD59 ELISA Kit |
ERP0359 |
Abclonal |
96Tests |
EUR 625.2 |
Goat CD59 ELISA Kit |
EGTP0359 |
Abclonal |
96Tests |
EUR 625.2 |
Monkey CD59 ELISA Kit |
EMKP0359 |
Abclonal |
96Tests |
EUR 625.2 |
Mouse CD59 ELISA Kit |
EMP0359 |
Abclonal |
96Tests |
EUR 625.2 |
Human CD59 ELISA Kit |
EHP0359 |
Abclonal |
96Tests |
EUR 625.2 |
Bovine CD59 ELISA Kit |
EBP0359 |
Abclonal |
96Tests |
EUR 625.2 |
Canine CD59 ELISA Kit |
ECP0359 |
Abclonal |
96Tests |
EUR 625.2 |
Anserini CD59 ELISA Kit |
EAP0359 |
Abclonal |
96Tests |
EUR 625.2 |
CD59 antibody |
70R-16284 |
Fitzgerald |
50 ul |
EUR 522 |
Description: Rabbit polyclonal CD59 antibody |
CD59 Antibody |
32388-100ul |
SAB |
100ul |
EUR 302.4 |
CD59 Antibody |
49441-100ul |
SAB |
100ul |
EUR 399.6 |
CD59 Antibody |
49441-50ul |
SAB |
50ul |
EUR 286.8 |
CD59 antibody |
10C-CR2040M1 |
Fitzgerald |
100 ug |
EUR 406.8 |
Description: Mouse monoclonal CD59 antibody |
CD59 Protein |
20-abx263374 |
Abbexa |
-
EUR 1930.80
-
EUR 393.60
-
EUR 276.00
|
|
|
CD59 siRNA |
20-abx911052 |
Abbexa |
|
|
|
CD59 siRNA |
20-abx911053 |
Abbexa |
|
|
|
CD59 Antibody |
7235-002mg |
ProSci |
0.02 mg |
EUR 206.18 |
|
Description: CD59 Antibody: The complement regulatory protein CD59 is a cell surface glycoprotein that regulates complement-mediated cell lysis and is involved in lymphocyte signal transduction. CD59 is a potent inhibitor of the complement membrane attack complex, whereby it binds complement C8 and/or C9 during the assembly of this complex, thereby inhibiting the incorporation of multiple copies of C9 into the complex, which is necessary for osmolytic pore formation. CD59 also plays a role in signal transduction pathways in the activation of T cells. Mutations in this gene cause CD59 deficiency, a disease resulting in hemolytic anemia and thrombosis, and ultimately cerebral infarction. |
CD59 Antibody |
7235-01mg |
ProSci |
0.1 mg |
EUR 523.7 |
|
Description: CD59 Antibody: The complement regulatory protein CD59 is a cell surface glycoprotein that regulates complement-mediated cell lysis and is involved in lymphocyte signal transduction. CD59 is a potent inhibitor of the complement membrane attack complex, whereby it binds complement C8 and/or C9 during the assembly of this complex, thereby inhibiting the incorporation of multiple copies of C9 into the complex, which is necessary for osmolytic pore formation. CD59 also plays a role in signal transduction pathways in the activation of T cells. Mutations in this gene cause CD59 deficiency, a disease resulting in hemolytic anemia and thrombosis, and ultimately cerebral infarction. |
CD59 Peptide |
7235P |
ProSci |
0.05 mg |
EUR 197.7 |
Description: (NT) CD59 Peptide |
CD59 Antibody |
1-CSB-PA569443 |
Cusabio |
|
|
|
Description: A polyclonal antibody against CD59. Recognizes CD59 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:1000-1:5000, IHC:1:25-1:100 |
CD59 Antibody |
1-CSB-PA778176 |
Cusabio |
|
|
|
Description: A polyclonal antibody against CD59. Recognizes CD59 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;ELISA:1:2000-1:10000, WB:1:500-1:2000, IHC:1:100-1:300 |
CD59 Antibody |
1-CSB-PA004947EA01HU |
Cusabio |
|
|
|
Description: A polyclonal antibody against CD59. Recognizes CD59 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC; Recommended dilution: IHC:1:20-1:200 |
CD59 Antibody |
1-CSB-PA004947GA01HU |
Cusabio |
|
|
|
Description: A polyclonal antibody against CD59. Recognizes CD59 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC |
CD59 Antibody |
1-CSB-PA004947YA01HU |
Cusabio |
|
|
|
Description: A polyclonal antibody against CD59. Recognizes CD59 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC; Recommended dilution: WB:1:1000-1:5000, IHC:1:20-1:200 |
CD59 Antibody |
1-CSB-PA005228 |
Cusabio |
|
|
|
Description: A polyclonal antibody against CD59. Recognizes CD59 from Human. This antibody is Unconjugated. Tested in the following application: WB, ELISA;WB:1/500-1/2000.ELISA:1/20000 |
anti-CD59 |
YF-PA10808 |
Abfrontier |
50 ug |
EUR 435.6 |
Description: Mouse polyclonal to CD59 |
anti-CD59 |
YF-PA10810 |
Abfrontier |
100 ug |
EUR 483.6 |
Description: Rabbit polyclonal to CD59 |
CD59 Antibody |
V3020-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: Reacts with human CD59, a 20kDa glycosyl phosphatidyl-inositol (GPI)-anchored cell surface protein (Workshop VI; Code N-L036). CD59 regulates complement-mediated cell lysis, and it is involved in lymphocyte signal transduction. This protein is a potent inhibitor of the complement membrane attack complex, whereby it binds complement C8 and/or C9 during the assembly of this complex, thereby inhibiting the incorporation of multiple copies of C9 into the complex, which is necessary for osmolytic pore formation. CD59 is widely distributed on cells in all tissues. It inhibits formation of MAC, thus protecting cells from complement-mediated lysis. The expression of CD59 on erythrocytes is important for their survival. Genetic defects in GPI-anchor attachment, that cause a reduction or loss of CD59 and CD55 on erythrocytes produce the symptoms of the disease paroxysmal hemoglobinuria (PNH). This mAb recognizes CD59 transfected cells. It is useful for study on GPI-anchored proteins, PNH and CD59 functions. |
CD59 Antibody |
V3020-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
Description: Reacts with human CD59, a 20kDa glycosyl phosphatidyl-inositol (GPI)-anchored cell surface protein (Workshop VI; Code N-L036). CD59 regulates complement-mediated cell lysis, and it is involved in lymphocyte signal transduction. This protein is a potent inhibitor of the complement membrane attack complex, whereby it binds complement C8 and/or C9 during the assembly of this complex, thereby inhibiting the incorporation of multiple copies of C9 into the complex, which is necessary for osmolytic pore formation. CD59 is widely distributed on cells in all tissues. It inhibits formation of MAC, thus protecting cells from complement-mediated lysis. The expression of CD59 on erythrocytes is important for their survival. Genetic defects in GPI-anchor attachment, that cause a reduction or loss of CD59 and CD55 on erythrocytes produce the symptoms of the disease paroxysmal hemoglobinuria (PNH). This mAb recognizes CD59 transfected cells. It is useful for study on GPI-anchored proteins, PNH and CD59 functions. |
CD59 Antibody |
V3020SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: Reacts with human CD59, a 20kDa glycosyl phosphatidyl-inositol (GPI)-anchored cell surface protein (Workshop VI; Code N-L036). CD59 regulates complement-mediated cell lysis, and it is involved in lymphocyte signal transduction. This protein is a potent inhibitor of the complement membrane attack complex, whereby it binds complement C8 and/or C9 during the assembly of this complex, thereby inhibiting the incorporation of multiple copies of C9 into the complex, which is necessary for osmolytic pore formation. CD59 is widely distributed on cells in all tissues. It inhibits formation of MAC, thus protecting cells from complement-mediated lysis. The expression of CD59 on erythrocytes is important for their survival. Genetic defects in GPI-anchor attachment, that cause a reduction or loss of CD59 and CD55 on erythrocytes produce the symptoms of the disease paroxysmal hemoglobinuria (PNH). This mAb recognizes CD59 transfected cells. It is useful for study on GPI-anchored proteins, PNH and CD59 functions. |
CD59 Antibody |
V3021-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: Reacts with human CD59, a 20kDa glycosyl phosphatidyl-inositol (GPI)-anchored cell surface protein. CD59 regulates complement-mediated cell lysis, and it is involved in lymphocyte signal transduction. This protein is a potent inhibitor of the complement membrane attack complex, whereby it binds complement C8 and/or C9 during the assembly of this complex, thereby inhibiting the incorporation of multiple copies of C9 into the complex, which is necessary for osmolytic pore formation. CD59 is widely distributed on cells in all tissues. It inhibits formation of MAC, thus protecting cells from complement-mediated lysis. The expression of CD59 on erythrocytes is important for their survival. Genetic defects in GPI-anchor attachment, that cause a reduction or loss of CD59 and CD55 on erythrocytes produce the symptoms of the disease paroxysmal hemoglobinuria (PNH). This mAb is useful for study on GPI-anchored proteins, PNH and CD59 functions. |
CD59 Antibody |
V3021-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
Description: Reacts with human CD59, a 20kDa glycosyl phosphatidyl-inositol (GPI)-anchored cell surface protein. CD59 regulates complement-mediated cell lysis, and it is involved in lymphocyte signal transduction. This protein is a potent inhibitor of the complement membrane attack complex, whereby it binds complement C8 and/or C9 during the assembly of this complex, thereby inhibiting the incorporation of multiple copies of C9 into the complex, which is necessary for osmolytic pore formation. CD59 is widely distributed on cells in all tissues. It inhibits formation of MAC, thus protecting cells from complement-mediated lysis. The expression of CD59 on erythrocytes is important for their survival. Genetic defects in GPI-anchor attachment, that cause a reduction or loss of CD59 and CD55 on erythrocytes produce the symptoms of the disease paroxysmal hemoglobinuria (PNH). This mAb is useful for study on GPI-anchored proteins, PNH and CD59 functions. |
CD59 Antibody |
V3021SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: Reacts with human CD59, a 20kDa glycosyl phosphatidyl-inositol (GPI)-anchored cell surface protein. CD59 regulates complement-mediated cell lysis, and it is involved in lymphocyte signal transduction. This protein is a potent inhibitor of the complement membrane attack complex, whereby it binds complement C8 and/or C9 during the assembly of this complex, thereby inhibiting the incorporation of multiple copies of C9 into the complex, which is necessary for osmolytic pore formation. CD59 is widely distributed on cells in all tissues. It inhibits formation of MAC, thus protecting cells from complement-mediated lysis. The expression of CD59 on erythrocytes is important for their survival. Genetic defects in GPI-anchor attachment, that cause a reduction or loss of CD59 and CD55 on erythrocytes produce the symptoms of the disease paroxysmal hemoglobinuria (PNH). This mAb is useful for study on GPI-anchored proteins, PNH and CD59 functions. |
CD59 Antibody |
V3022-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: Reacts with human CD59, a 20kDa glycosyl phosphatidyl-inositol (GPI)-anchored cell surface protein. CD59 regulates complement-mediated cell lysis, and it is involved in lymphocyte signal transduction. This protein is a potent inhibitor of the complement membrane attack complex, whereby it binds complement C8 and/or C9 during the assembly of this complex, thereby inhibiting the incorporation of multiple copies of C9 into the complex, which is necessary for osmolytic pore formation. It inhibits formation of MAC, thus protecting cells from complement-mediated lysis. Genetic defects in GPI-anchor attachment, that cause a reduction or loss of CD59 and CD55 on erythrocytes produce the symptoms of the disease paroxysmal hemoglobinuria (PNH). This MAb is useful for study on GPI-anchored proteins, PNH and CD59 functions. CD59 is widely distributed on cells in all tissues. The expression of CD59 on erythrocytes is important for their survival. |
CD59 Antibody |
V3022-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
Description: Reacts with human CD59, a 20kDa glycosyl phosphatidyl-inositol (GPI)-anchored cell surface protein. CD59 regulates complement-mediated cell lysis, and it is involved in lymphocyte signal transduction. This protein is a potent inhibitor of the complement membrane attack complex, whereby it binds complement C8 and/or C9 during the assembly of this complex, thereby inhibiting the incorporation of multiple copies of C9 into the complex, which is necessary for osmolytic pore formation. It inhibits formation of MAC, thus protecting cells from complement-mediated lysis. Genetic defects in GPI-anchor attachment, that cause a reduction or loss of CD59 and CD55 on erythrocytes produce the symptoms of the disease paroxysmal hemoglobinuria (PNH). This MAb is useful for study on GPI-anchored proteins, PNH and CD59 functions. CD59 is widely distributed on cells in all tissues. The expression of CD59 on erythrocytes is important for their survival. |
CD59 Antibody |
V3022IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 499 |
Description: Reacts with human CD59, a 20kDa glycosyl phosphatidyl-inositol (GPI)-anchored cell surface protein. CD59 regulates complement-mediated cell lysis, and it is involved in lymphocyte signal transduction. This protein is a potent inhibitor of the complement membrane attack complex, whereby it binds complement C8 and/or C9 during the assembly of this complex, thereby inhibiting the incorporation of multiple copies of C9 into the complex, which is necessary for osmolytic pore formation. It inhibits formation of MAC, thus protecting cells from complement-mediated lysis. Genetic defects in GPI-anchor attachment, that cause a reduction or loss of CD59 and CD55 on erythrocytes produce the symptoms of the disease paroxysmal hemoglobinuria (PNH). This MAb is useful for study on GPI-anchored proteins, PNH and CD59 functions. CD59 is widely distributed on cells in all tissues. The expression of CD59 on erythrocytes is important for their survival. |
CD59 Antibody |
V3022SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: Reacts with human CD59, a 20kDa glycosyl phosphatidyl-inositol (GPI)-anchored cell surface protein. CD59 regulates complement-mediated cell lysis, and it is involved in lymphocyte signal transduction. This protein is a potent inhibitor of the complement membrane attack complex, whereby it binds complement C8 and/or C9 during the assembly of this complex, thereby inhibiting the incorporation of multiple copies of C9 into the complex, which is necessary for osmolytic pore formation. It inhibits formation of MAC, thus protecting cells from complement-mediated lysis. Genetic defects in GPI-anchor attachment, that cause a reduction or loss of CD59 and CD55 on erythrocytes produce the symptoms of the disease paroxysmal hemoglobinuria (PNH). This MAb is useful for study on GPI-anchored proteins, PNH and CD59 functions. CD59 is widely distributed on cells in all tissues. The expression of CD59 on erythrocytes is important for their survival. |
CD59 Antibody |
V3023-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: CD59 is a glycosyl phosphatidyl-inositol (GPI)-anchored cell surface protein. CD59 attaches to host cells via a glycophosphatidylinositol (GPI) anchor. When complement activation leads to deposition of C5b678 on host cells, it can prevent C9 from polymerizing and forming the complement membrane attack complex. Mutations affecting GPI that reduce expression of CD59 and decay-accelerating factor on red blood cells result in paroxysmal nocturnal hemoglobinuria. Viruses such as HIV, human cytomegalovirus and vaccinia incorporate host cell CD59 into their own viral envelope to prevent lysis by complement. [Wiki] |
CD59 Antibody |
V3023-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
Description: CD59 is a glycosyl phosphatidyl-inositol (GPI)-anchored cell surface protein. CD59 attaches to host cells via a glycophosphatidylinositol (GPI) anchor. When complement activation leads to deposition of C5b678 on host cells, it can prevent C9 from polymerizing and forming the complement membrane attack complex. Mutations affecting GPI that reduce expression of CD59 and decay-accelerating factor on red blood cells result in paroxysmal nocturnal hemoglobinuria. Viruses such as HIV, human cytomegalovirus and vaccinia incorporate host cell CD59 into their own viral envelope to prevent lysis by complement. [Wiki] |
CD59 Antibody |
V3023SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: CD59 is a glycosyl phosphatidyl-inositol (GPI)-anchored cell surface protein. CD59 attaches to host cells via a glycophosphatidylinositol (GPI) anchor. When complement activation leads to deposition of C5b678 on host cells, it can prevent C9 from polymerizing and forming the complement membrane attack complex. Mutations affecting GPI that reduce expression of CD59 and decay-accelerating factor on red blood cells result in paroxysmal nocturnal hemoglobinuria. Viruses such as HIV, human cytomegalovirus and vaccinia incorporate host cell CD59 into their own viral envelope to prevent lysis by complement. [Wiki] |
CD59 Antibody |
V3024-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: Reacts with human CD59, a 20kDa glycosyl phosphatidyl-inositol (GPI)-anchored cell surface protein. CD59 regulates complement-mediated cell lysis, and it is involved in lymphocyte signal transduction. This protein is a potent inhibitor of the complement membrane attack complex, whereby it binds complement C8 and/or C9 during the assembly of this complex, thereby inhibiting the incorporation of multiple copies of C9 into the complex, which is necessary for osmolytic pore formation. CD59 is widely distributed on cells in all tissues. It inhibits formation of MAC, thus protecting cells from complement-mediated lysis. The expression of CD59 on erythrocytes is important for their survival. Genetic defects in GPI-anchor attachment, that cause a reduction or loss of CD59 and CD55 on erythrocytes produce the symptoms of the disease paroxysmal hemoglobinuria (PNH). It is useful for study on GPI-anchored proteins, PNH and CD59 functions. |
CD59 Antibody |
V3024-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
Description: Reacts with human CD59, a 20kDa glycosyl phosphatidyl-inositol (GPI)-anchored cell surface protein. CD59 regulates complement-mediated cell lysis, and it is involved in lymphocyte signal transduction. This protein is a potent inhibitor of the complement membrane attack complex, whereby it binds complement C8 and/or C9 during the assembly of this complex, thereby inhibiting the incorporation of multiple copies of C9 into the complex, which is necessary for osmolytic pore formation. CD59 is widely distributed on cells in all tissues. It inhibits formation of MAC, thus protecting cells from complement-mediated lysis. The expression of CD59 on erythrocytes is important for their survival. Genetic defects in GPI-anchor attachment, that cause a reduction or loss of CD59 and CD55 on erythrocytes produce the symptoms of the disease paroxysmal hemoglobinuria (PNH). It is useful for study on GPI-anchored proteins, PNH and CD59 functions. |
CD59 Antibody |
V3024IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 499 |
Description: Reacts with human CD59, a 20kDa glycosyl phosphatidyl-inositol (GPI)-anchored cell surface protein. CD59 regulates complement-mediated cell lysis, and it is involved in lymphocyte signal transduction. This protein is a potent inhibitor of the complement membrane attack complex, whereby it binds complement C8 and/or C9 during the assembly of this complex, thereby inhibiting the incorporation of multiple copies of C9 into the complex, which is necessary for osmolytic pore formation. CD59 is widely distributed on cells in all tissues. It inhibits formation of MAC, thus protecting cells from complement-mediated lysis. The expression of CD59 on erythrocytes is important for their survival. Genetic defects in GPI-anchor attachment, that cause a reduction or loss of CD59 and CD55 on erythrocytes produce the symptoms of the disease paroxysmal hemoglobinuria (PNH). It is useful for study on GPI-anchored proteins, PNH and CD59 functions. |
CD59 Antibody |
V3024SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: Reacts with human CD59, a 20kDa glycosyl phosphatidyl-inositol (GPI)-anchored cell surface protein. CD59 regulates complement-mediated cell lysis, and it is involved in lymphocyte signal transduction. This protein is a potent inhibitor of the complement membrane attack complex, whereby it binds complement C8 and/or C9 during the assembly of this complex, thereby inhibiting the incorporation of multiple copies of C9 into the complex, which is necessary for osmolytic pore formation. CD59 is widely distributed on cells in all tissues. It inhibits formation of MAC, thus protecting cells from complement-mediated lysis. The expression of CD59 on erythrocytes is important for their survival. Genetic defects in GPI-anchor attachment, that cause a reduction or loss of CD59 and CD55 on erythrocytes produce the symptoms of the disease paroxysmal hemoglobinuria (PNH). It is useful for study on GPI-anchored proteins, PNH and CD59 functions. |
CD59 Antibody |
V7168-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: CD59 is a potent inhibitor of the complement membrane attack complex (MAC) action. Acts by binding to the C8 and/or C9 complements of the assembling MAC, thereby preventing incorporation of the multiple copies of C9 required for complete formation of the osmolytic pore. This inhibitor appears to be species-specific. Involved in signal transduction for T-cell activation complexed to a protein tyrosine kinase. The soluble form from urine retains its specific complement binding activity, but exhibits greatly reduced ability to inhibit MAC assembly on cell membranes. [UniProt] |
CD59 Antibody |
V7168-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
Description: CD59 is a potent inhibitor of the complement membrane attack complex (MAC) action. Acts by binding to the C8 and/or C9 complements of the assembling MAC, thereby preventing incorporation of the multiple copies of C9 required for complete formation of the osmolytic pore. This inhibitor appears to be species-specific. Involved in signal transduction for T-cell activation complexed to a protein tyrosine kinase. The soluble form from urine retains its specific complement binding activity, but exhibits greatly reduced ability to inhibit MAC assembly on cell membranes. [UniProt] |
CD59 Antibody |
V7168IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 499 |
Description: CD59 is a potent inhibitor of the complement membrane attack complex (MAC) action. Acts by binding to the C8 and/or C9 complements of the assembling MAC, thereby preventing incorporation of the multiple copies of C9 required for complete formation of the osmolytic pore. This inhibitor appears to be species-specific. Involved in signal transduction for T-cell activation complexed to a protein tyrosine kinase. The soluble form from urine retains its specific complement binding activity, but exhibits greatly reduced ability to inhibit MAC assembly on cell membranes. [UniProt] |
CD59 Antibody |
V7168SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: CD59 is a potent inhibitor of the complement membrane attack complex (MAC) action. Acts by binding to the C8 and/or C9 complements of the assembling MAC, thereby preventing incorporation of the multiple copies of C9 required for complete formation of the osmolytic pore. This inhibitor appears to be species-specific. Involved in signal transduction for T-cell activation complexed to a protein tyrosine kinase. The soluble form from urine retains its specific complement binding activity, but exhibits greatly reduced ability to inhibit MAC assembly on cell membranes. [UniProt] |
CD59 Antibody |
V7387-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: Reacts with human CD59, a 20kDa glycosyl phosphatidyl-inositol (GPI)-anchored cell surface protein. CD59 regulates complement-mediated cell lysis, and it is involved in lymphocyte signal transduction. This protein is a potent inhibitor of the complement membrane attack complex, whereby it binds complement C8 and/or C9 during the assembly of this complex, thereby inhibiting the incorporation of multiple copies of C9 into the complex, which is necessary for osmolytic pore formation. CD59 is widely distributed on cells in all tissues. It inhibits formation of MAC, thus protecting cells from complement-mediated lysis. The expression of CD59 on erythrocytes is important for their survival. Genetic defects in GPI-anchor attachment, that cause a reduction or loss of CD59 and CD55 on erythrocytes produce the symptoms of the disease paroxysmal hemoglobinuria (PNH). It is useful for study on GPI-anchored proteins, PNH and CD59 functions. |
CD59 Antibody |
V7387-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
Description: Reacts with human CD59, a 20kDa glycosyl phosphatidyl-inositol (GPI)-anchored cell surface protein. CD59 regulates complement-mediated cell lysis, and it is involved in lymphocyte signal transduction. This protein is a potent inhibitor of the complement membrane attack complex, whereby it binds complement C8 and/or C9 during the assembly of this complex, thereby inhibiting the incorporation of multiple copies of C9 into the complex, which is necessary for osmolytic pore formation. CD59 is widely distributed on cells in all tissues. It inhibits formation of MAC, thus protecting cells from complement-mediated lysis. The expression of CD59 on erythrocytes is important for their survival. Genetic defects in GPI-anchor attachment, that cause a reduction or loss of CD59 and CD55 on erythrocytes produce the symptoms of the disease paroxysmal hemoglobinuria (PNH). It is useful for study on GPI-anchored proteins, PNH and CD59 functions. |
CD59 Antibody |
V7387IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 499 |
Description: Reacts with human CD59, a 20kDa glycosyl phosphatidyl-inositol (GPI)-anchored cell surface protein. CD59 regulates complement-mediated cell lysis, and it is involved in lymphocyte signal transduction. This protein is a potent inhibitor of the complement membrane attack complex, whereby it binds complement C8 and/or C9 during the assembly of this complex, thereby inhibiting the incorporation of multiple copies of C9 into the complex, which is necessary for osmolytic pore formation. CD59 is widely distributed on cells in all tissues. It inhibits formation of MAC, thus protecting cells from complement-mediated lysis. The expression of CD59 on erythrocytes is important for their survival. Genetic defects in GPI-anchor attachment, that cause a reduction or loss of CD59 and CD55 on erythrocytes produce the symptoms of the disease paroxysmal hemoglobinuria (PNH). It is useful for study on GPI-anchored proteins, PNH and CD59 functions. |
CD59 Antibody |
V7387SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: Reacts with human CD59, a 20kDa glycosyl phosphatidyl-inositol (GPI)-anchored cell surface protein. CD59 regulates complement-mediated cell lysis, and it is involved in lymphocyte signal transduction. This protein is a potent inhibitor of the complement membrane attack complex, whereby it binds complement C8 and/or C9 during the assembly of this complex, thereby inhibiting the incorporation of multiple copies of C9 into the complex, which is necessary for osmolytic pore formation. CD59 is widely distributed on cells in all tissues. It inhibits formation of MAC, thus protecting cells from complement-mediated lysis. The expression of CD59 on erythrocytes is important for their survival. Genetic defects in GPI-anchor attachment, that cause a reduction or loss of CD59 and CD55 on erythrocytes produce the symptoms of the disease paroxysmal hemoglobinuria (PNH). It is useful for study on GPI-anchored proteins, PNH and CD59 functions. |
CD59 Antibody |
RQ6078 |
NSJ Bioreagents |
100 ug |
EUR 419 |
Description: This gene encodes a cell surface glycoprotein that regulates complement-mediated cell lysis, and it is involved in lymphocyte signal transduction. And this protein is a potent inhibitor of the complement membrane attack complex, whereby it binds complement C8 and/or C9 during the assembly of this complex, thereby inhibiting the incorporation of multiple copies of C9 into the complex, which is necessary for osmolytic pore formation. It also plays a role in signal transduction pathways in the activation of T cells. Mutations in this gene cause CD59 deficiency, a disease resulting in hemolytic anemia and thrombosis, and which causes cerebral infarction. Multiple alternatively spliced transcript variants, which encode the same protein, have been identified for this gene. |
CD59 ELISA Kit (Human) (OKAN05355) |
OKAN05355 |
Aviva Systems Biology |
96 Wells |
EUR 950.4 |
Description: Description of target: This gene encodes a cell surface glycoprotein that regulates complement-mediated cell lysis, and it is involved in lymphocyte signal transduction. This protein is a potent inhibitor of the complement membrane attack complex, whereby it binds complement C8 and/or C9 during the assembly of this complex, thereby inhibiting the incorporation of multiple copies of C9 into the complex, which is necessary for osmolytic pore formation. This protein also plays a role in signal transduction pathways in the activation of T cells. Mutations in this gene cause CD59 deficiency, a disease resulting in hemolytic anemia and thrombosis, and which causes cerebral infarction. Multiple alternatively spliced transcript variants, which encode the same protein, have been identified for this gene.;Species reactivity: Human;Application: ELISA;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 5.5 pg/mL |
Guinea Pig CD59 ELISA Kit |
EGP0359 |
Abclonal |
96Tests |
EUR 625.2 |
CD59 ELISA Kit (Human) (OKCD07331) |
OKCD07331 |
Aviva Systems Biology |
96 Wells |
EUR 1123.2 |
Description: Description of target: This gene encodes a cell surface glycoprotein that regulates complement-mediated cell lysis, and it is involved in lymphocyte signal transduction. This protein is a potent inhibitor of the complement membrane attack complex, whereby it binds complement C8 and/or C9 during the assembly of this complex, thereby inhibiting the incorporation of multiple copies of C9 into the complex, which is necessary for osmolytic pore formation. This protein also plays a role in signal transduction pathways in the activation of T cells. Mutations in this gene cause CD59 deficiency, a disease resulting in hemolytic anemia and thrombosis, and which causes cerebral infarction. Multiple alternatively spliced transcript variants, which encode the same protein, have been identified for this gene.;Species reactivity: Human;Application: ELISA;Assay info: ;Sensitivity: < 5.5pg/mL |
Human Protectin (CD59) ELISA Kit |
SEB336Hu-10x96wellstestplate |
Cloud-Clone |
10x96-wells test plate |
EUR 5402.92 |
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Protectin (CD59) in serum, plasma, cell lysates and other biological fluids. |
Human Protectin (CD59) ELISA Kit |
SEB336Hu-1x48wellstestplate |
Cloud-Clone |
1x48-wells test plate |
EUR 550.13 |
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Protectin (CD59) in serum, plasma, cell lysates and other biological fluids. |
Human Protectin (CD59) ELISA Kit |
SEB336Hu-1x96wellstestplate |
Cloud-Clone |
1x96-wells test plate |
EUR 734.46 |
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Protectin (CD59) in serum, plasma, cell lysates and other biological fluids. |
Human Protectin (CD59) ELISA Kit |
SEB336Hu-5x96wellstestplate |
Cloud-Clone |
5x96-wells test plate |
EUR 2945.08 |
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Protectin (CD59) in serum, plasma, cell lysates and other biological fluids. |
Human Protectin (CD59) ELISA Kit |
4-SEB336Hu |
Cloud-Clone |
-
EUR 5463.60
-
EUR 2886.00
-
EUR 735.60
|
- 10 plates of 96 wells
- 5 plates of 96 wells
- 1 plate of 96 wells
|
|
Description: Enzyme-linked immunosorbent assay based on the Double-antibody Sandwich method for detection of Human Protectin (CD59) in samples from Serum, plasma, cell lysates and other biological fluids with no significant corss-reactivity with analogues from other species. |
Mouse Protectin (CD59) ELISA Kit |
SEB336Mu-10x96wellstestplate |
Cloud-Clone |
10x96-wells test plate |
EUR 5552.14 |
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Mouse Protectin (CD59) in serum, plasma, urine and other biological fluids. |
Mouse Protectin (CD59) ELISA Kit |
SEB336Mu-1x48wellstestplate |
Cloud-Clone |
1x48-wells test plate |
EUR 562.42 |
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Mouse Protectin (CD59) in serum, plasma, urine and other biological fluids. |
Mouse Protectin (CD59) ELISA Kit |
SEB336Mu-1x96wellstestplate |
Cloud-Clone |
1x96-wells test plate |
EUR 752.02 |
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Mouse Protectin (CD59) in serum, plasma, urine and other biological fluids. |
Mouse Protectin (CD59) ELISA Kit |
SEB336Mu-5x96wellstestplate |
Cloud-Clone |
5x96-wells test plate |
EUR 3024.07 |
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Mouse Protectin (CD59) in serum, plasma, urine and other biological fluids. |
Mouse Protectin (CD59) ELISA Kit |
4-SEB336Mu |
Cloud-Clone |
-
EUR 5612.40
-
EUR 2965.20
-
EUR 752.40
|
- 10 plates of 96 wells
- 5 plates of 96 wells
- 1 plate of 96 wells
|
|
Description: Enzyme-linked immunosorbent assay based on the Double-antibody Sandwich method for detection of Mouse Protectin (CD59) in samples from Serum, plasma, urine and other biological fluids. with no significant corss-reactivity with analogues from other species. |
Human Protectin ELISA Kit (CD59) |
RK01072 |
Abclonal |
96 Tests |
EUR 625.2 |
CD59 antibody (FITC) |
61R-CD59HUFT |
Fitzgerald |
25 tests |
EUR 230.4 |
Description: Mouse monoclonal CD59 antibody (FITC) |
CD59 antibody (PE) |
61R-CD59HUPE |
Fitzgerald |
25 tests |
EUR 230.4 |
Description: Mouse monoclonal CD59 antibody (PE) |
CD59 Rabbit pAb |
A12412-100ul |
Abclonal |
100 ul |
EUR 369.6 |
CD59 Rabbit pAb |
A12412-200ul |
Abclonal |
200 ul |
EUR 550.8 |
CD59 Rabbit pAb |
A12412-20ul |
Abclonal |
20 ul |
EUR 219.6 |
CD59 Rabbit pAb |
A12412-50ul |
Abclonal |
50 ul |
EUR 267.6 |
CD59 Monoclonal Antibody |
42018-100ul |
SAB |
100ul |
EUR 399.6 |
CD59 Polyclonal Antibody |
41659-100ul |
SAB |
100ul |
EUR 302.4 |
CD59 Polyclonal Antibody |
41659-50ul |
SAB |
50ul |
EUR 224.4 |
CD59 Recombinant Protein |
11-232 |
ProSci |
0.1 mg |
EUR 651.3 |
Description: CD59, also known as membrane attack complex inhibition factor (MACIF), Protectin, 1F5 antigen, HRF-20 and MIRL. CD59 has been identified as a glycosylphosphatidylinositol-anchored membrane protein that acts as an inhibitor of the formation of the membrane attack complex to regulate complement activation. Potent inhibitor of the complement membrane attack complex (MAC) action. Acts by binding to the C8 and/or C9 complements of the assembling MAC, thereby preventing incorporation of the multiple copies of C9 required for complete formation of the osmolytic pore. This inhibitor appears to be species-specific. Involved in signal transduction for T-cell activation complexed to a protein tyrosine kinase. |
Protectin (CD59) Antibody |
abx139305-01mg |
Abbexa |
0.1 mg |
EUR 427.2 |
|
Protectin (CD59) Antibody |
abx139306-01mg |
Abbexa |
0.1 mg |
EUR 444 |
|
Protectin (CD59) Antibody |
abx139307-01mg |
Abbexa |
0.1 mg |
EUR 427.2 |
|
Protectin (CD59) Antibody |
20-abx132385 |
Abbexa |
-
EUR 393.60
-
EUR 1011.60
-
EUR 526.80
-
EUR 184.80
-
EUR 309.60
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
CD59 Polyclonal Antibody |
ABP52983-003ml |
Abbkine |
0.03ml |
EUR 189.6 |
|
Description: A polyclonal antibody for detection of CD59 from Human. This CD59 antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human CD59 |
CD59 Polyclonal Antibody |
ABP52983-01ml |
Abbkine |
0.1ml |
EUR 346.8 |
|
Description: A polyclonal antibody for detection of CD59 from Human. This CD59 antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human CD59 |
Normal, chlorophyll-deficient, and flavonoid-deficient pigment isolines of two soybean (Glycine max) cultivars that produced totally different flavonol glycosides (Harosoy produced kaempferol, Clark produced quercetin and kaempferol) had been examined. Plants with larger ranges of complete flavonoids, not particular flavonol glycosides, had been extra UV-B tolerant as decided by progress, pigment, and gas-exchange variables.